Letters FINE trial for CFS

Authors’ reply

BMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c2992 (Published 09 June 2010) Cite this as: BMJ 2010;340:c2992
  1. Alison J Wearden, reader in psychology1,
  2. Christopher Dowrick, professor of primary medical care2,
  3. Carolyn Chew-Graham, professor of primary care3,
  4. Richard P Bentall, professor of clinical psychology4,
  5. Richard K Morriss, professor of psychiatry and community mental health5,
  6. Sarah Peters, senior lecturer in psychology1,
  7. Lisa Riste, FINE trial manager1,
  8. Gerry Richardson, senior research fellow in health economics67,
  9. Karina Lovell, professor of mental health8,
  10. Graham Dunn, professor of biomedical statistics3
  1. 1School of Psychological Sciences, University of Manchester, Manchester M13 9PL
  2. 2School of Population, Community and Behavioural Sciences, University of Liverpool, Liverpool
  3. 3School of Community Based Medicine, University of Manchester, Manchester
  4. 4School of Psychology, University of Bangor, Adeilad Brigantia, Bangor, Gwynedd
  5. 5School of Community Health Sciences, Institute of Mental Health, University of Nottingham, Nottingham
  6. 6Centre for Health Economics, University of York, York
  7. 7Hull York Medical School, University of York, Heslington, York
  8. 8School of Nursing, Midwifery and Social Work, University of Manchester, Manchester
  1. alison.wearden{at}manchester.ac.uk

    We agree with Carter and other correspondents that the fatigue scale is limited by a ceiling effect, but this is more of a problem at baseline (before treatment starts) than at follow-up assessments.1 2 With the fatigue scale re-scored to 0, 1, 2, 3, we can demonstrate a …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe